Add Yahoo as a preferred source to see more of our stories on Google. As the calendar turns, many people start thinking less about reinvention and more about momentum. A new year is a clean slate, a ...

A once-weekly injectable GIP/GLP-1 dual agonist conferred up to 22.5% weight loss at 48 weeks for adults with overweight or ...

This article was reviewed by Darragh O’Carroll, MD. Key Takeaways: Medical weight loss is a personalized, medically ...

You don’t have to make drastic changes or go to extremes to lose weight. There are low-effort but effective ways to lose weight, including simple nutrition swaps, time-saving hacks, and enjoyable ...

New weight loss drug by Pfizer shows promising results in trial - Pfizer acquired the drug’s developer following a bidding ...

Your body has a 'set-point' weight it wants to maintain. Learn how set-point theory affects your metabolism and the lifestyle shifts that could lower your natural weight range.

A once-weekly injectable glucose-dependent insulinotropic polypeptide/GLP-1 dual agonist conferred up to 14.7% weight loss at 13 weeks for adults with overweight or obesity, according to findings from ...

Blockbuster weight-loss shots are undergoing a major makeover. Drugs like Zepbound and Wegovy have already taken the US by storm — with the number of Americans using them to slim down more than ...

CagriSema achieved superior weight loss of up to 14.2%, where up to 43% of the people achieved ≥15% weight loss and up to 24% ...

As the calendar turns, many people start thinking less about reinvention and more about momentum. A new year is a clean slate, a chance to reset habits and recommit to goals that may have slipped ...